BTIG initiates coverage on Maze Therapeutics with a Buy rating and PT of $30.

martes, 2 de septiembre de 2025, 8:18 am ET1 min de lectura
MAZE--

BTIG initiates coverage on Maze Therapeutics with a Buy rating and PT of $30.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios